R&D INNOVATION
Technological innovation —
Chemical Active Pharmaceutical Ingredients
Detailed introduction
| Number |
Product Name |
Application |
Technical or regulatory status |
| 1 |
Marboxilav |
Influenza virus infection |
Process Validation |
| 2 |
Ruxolitinib phosphate |
Myelofibrosis |
Process Validation |
| 3 |
Litaist |
Dry Eye Syndrome |
Pilot testing |
| 4 |
Bromodiglycine |
Myasthenia Gravis |
Process Validation |
| 5 |
Bulixitan |
Epilepsy |
Process Validation |
| 6 |
Benidipine Hydrochloride |
Primary hypertension, angina pectoris |
Already declared |
| 7 |
Kainivatan |
Hyponatremia |
Already declared |
| 8 |
Sugammadex Sodium |
Muscle relaxant antagonist |
Already declared |
| 9 |
Linezolid |
Infections caused by specific microbial-sensitive strains |
CXHL1300397 |
| 10 |
Polyprill Zinc |
Stomach ulcer |
National Medical Product Approval Number H20120090 |
| 11 |
Clopidogrel bisulfate |
Platelet inhibitor |
CYHS1201638 |
| 12 |
Cinepazide Maleate |
Acute ischemic stroke |
CYHS1100004 |
| 13 |
Fasudil Hydrochloride |
Vascular spasm |
CYHS1100006 |
| 14 |
Sulfobutyl beta-cyclodextrin sodium |
Pharmaceutical excipients |
Already declared |
Note: Products protected by patents are intended solely for research and development purposes.
Keywords:
Previous page:
Next page: